PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma.
Petrulea, Mirela S
PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma. [electronic resource] - Cancer treatment reviews Sep 2015 - 707-13 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1532-1967
10.1016/j.ctrv.2015.06.005 doi
Carcinogenesis--drug effects
Carcinoma--drug therapy
Carcinoma, Papillary
Disease Management
Drug Resistance, Neoplasm
Humans
Molecular Targeted Therapy--methods
Mutation
Nuclear Proteins--genetics
Proto-Oncogene Proteins c-akt--genetics
Signal Transduction--genetics
TOR Serine-Threonine Kinases--genetics
Thyroid Cancer, Papillary
Thyroid Neoplasms--drug therapy
Transcription Factors--genetics
PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma. [electronic resource] - Cancer treatment reviews Sep 2015 - 707-13 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1532-1967
10.1016/j.ctrv.2015.06.005 doi
Carcinogenesis--drug effects
Carcinoma--drug therapy
Carcinoma, Papillary
Disease Management
Drug Resistance, Neoplasm
Humans
Molecular Targeted Therapy--methods
Mutation
Nuclear Proteins--genetics
Proto-Oncogene Proteins c-akt--genetics
Signal Transduction--genetics
TOR Serine-Threonine Kinases--genetics
Thyroid Cancer, Papillary
Thyroid Neoplasms--drug therapy
Transcription Factors--genetics